IP Library Granted Patent US 8,349,813
Granted Patent B2
US 8,349,813 · App. 12/407,516 · Granted Jan 8, 2013

Destruction of microbial products by enzymatic digestion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,349,813
App. No.
12/407,516
Granted
Jan 8, 2013
Kind
B2
Abstract

Methods of treating a dialysis component by providing a dialysis component and contacting the dialysis component with an enzyme are provided. The enzyme breaks down microbial contaminants in the dialysis component. The enzyme may be separated from the dialysis component to provide a purified dialysis component. The purified dialysis component may be substantially free of microbial contaminants that cause a cytokine response in humans.

Claims (35)

1. A method of treating a dialysis component, the method comprising:

providing a dialysis component for peritoneal dialysis;

contacting the dialysis component with an enzyme selected from the group consisting of N-acetylmuramyl-L-alanine amidase, lysozyme, amidases, trypsins, chitinases, beta 1-3 glucanases, pronases, proteases, lipases, endoglycosidases and combinations thereof;

allowing the enzyme to break down microbial contaminants in the dialysis component; and

separating the enzyme from the dialysis component to provide a purified dialysis component.

2. The method of claim 1 , wherein the purified dialysis component is substantially free of microbial contaminants that cause a cytokine response in humans.

3. The method of claim 1 , wherein the enzyme is added at a ratio of between about 0.0005% and about 0.05% by weight of the dialysis component.

4. The method of claim 1 , wherein the dialysis component is selected from the group consisting of glucose polymers, hydroxyethyl starch, modified starch and combinations thereof.

5. The method of claim 1 further comprising incubating the dialysis component and the enzyme for a period of time.

6. The method of claim 5 , wherein the period of time is at least 1 hour.

7. The method of claim 1 , wherein the step of contacting the dialysis component with an enzyme comprises adding to the dialysis component a treatment solution comprising the enzyme.

8. The method of claim 7 , wherein the step of separating the enzyme from the dialysis component comprises filtering the enzyme from the dialysis component.

9. The method of claim 8 , wherein the enzyme is naturally larger than the molecular weight cut off of the filter.

10. The method of claim 1 , wherein the enzyme is fixed to a substrate.

11. The method of claim 10 , wherein the substrate is a bead or a membrane.

12. The method of claim 1 , wherein the step of contacting the dialysis component with an enzyme is performed in a batch process.

13. The method of claim 1 , wherein the step of contacting the dialysis component with an enzyme is performed in a continuous process.

14. The method of claim 1 further comprising the step of testing the dialysis component for the presence of microbial contaminants after the step of allowing the enzyme to break down microbial contaminants in the dialysis component.

15. The method of claim 14 , where the testing is interleukin-6 testing.

16. The method of claim 1 , wherein the dialysis component includes peptidoglycan as a microbial contaminant.

17. The method of claim 1 , wherein the dialysis component is icodextrin.

18. A method of treating a peritoneal dialysis solution, the method comprising:

providing a peritoneal dialysis solution comprising a glucose polymer, hydroxyethyl starch or modified starch;

contacting the peritoneal dialysis solution with an enzyme selected from the group consisting of N-acetylmuramyl-L-alanine amidase, lysozyme, amidases, trypsins, chitinases, beta 1-3 glucanases, pronases, proteases, lipases, endoglycosidases and combinations thereof;

allowing the enzyme to break down microbial contaminants in the peritoneal dialysis solution; and

separating the enzyme from the peritoneal dialysis solution to provide a purified peritoneal dialysis solution.

19. The method of claim 18 , wherein the step of contacting the peritoneal dialysis solution with an enzyme comprises adding to the peritoneal dialysis solution a treatment solution comprising the enzyme.

20. The method of claim 18 , wherein the step of separating the enzyme from the peritoneal dialysis solution comprises filtering the enzyme from the peritoneal dialysis solution.

21. A method of providing peritoneal dialysis to a patient, the method comprising:

providing a peritoneal dialysis component comprising a glucose polymer, hydroxyethyl starch or modified starch;

contacting the peritoneal dialysis component with an enzyme selected from the group consisting of N-acetylmuramyl-L-alanine amidase, lysozyme, amidases, trypsins, chitinases, beta 1-3 glucanases, pronases, proteases, lipases, endoglycosidases and combinations thereof;

allowing the enzyme to break down microbial contaminants in the peritoneal dialysis component;

separating the enzyme from the peritoneal dialysis component to provide a purified peritoneal dialysis component;

using the purified peritoneal dialysis component to make a peritoneal dialysis solution; and

using the peritoneal dialysis solution in a treatment of a patient.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 073433/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074041/0750 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
CHANGE OF CORPORATE ADDRESS Recorded Dec 7, 2012
From: BAXTER HEALTHCARE S.A.
To: BAXTER HEALTHCARE S.A.
Reel/Frame 029427/0058 →
CHANGE OF CORPORATE ADDRESS Recorded Dec 6, 2012
From: BAXTER HEALTHCARE S.A.
To: BAXTER HEALTHCARE S.A.
Reel/Frame 029423/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2009
From: JOHNSON, RICHARD J.; LEESCH, VALERIE; HOLMES, CLIFFORD; WANG, RUN
To: BAXTER INTERNATIONAL LNC.; BAXTER HEALTHCARE S.A.
Reel/Frame 023689/0722 →